GlaxoSmithKline (GSK)

Create an Alert
51.48 -0.99  -1.89%   NYSE Jun 19, 8:00PM BATS Real time Currency in USD

GlaxoSmithKline Free Cash Flow:

1.413B for March 31, 2013
View Full Chart

GlaxoSmithKline Free Cash Flow Chart

    GlaxoSmithKline Historical Free Cash Flow Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 1.413B
    Dec. 31, 2012 2.225B
    Sept. 30, 2012 -936.65M
    June 30, 2012 2.105B
    March 31, 2012 1.208B
    Dec. 31, 2011 2.540B
    Sept. 30, 2011 2.330B
    June 30, 2011 1.568B
    March 31, 2011 1.150B
    Dec. 31, 2010 1.455B
    Sept. 30, 2010 1.179B
    June 30, 2010 2.661B
    March 31, 2010 2.707B
    Dec. 31, 2009 2.650B
    Sept. 30, 2009 2.555B
    June 30, 2009 2.469B
    March 31, 2009 1.921B
    Dec. 31, 2008 617.26M
    Sept. 30, 2008 2.040B
       
    June 30, 2008 1.811B
    March 31, 2008 Go Pro
    Dec. 31, 2007 Go Pro
    Sept. 30, 2007 Go Pro
    June 30, 2007 Go Pro
    March 31, 2007 Go Pro
    Dec. 31, 2006 Go Pro
    Sept. 30, 2006 Go Pro
    June 30, 2006 Go Pro
    March 31, 2006 Go Pro
    Dec. 31, 2005 Go Pro
    Sept. 30, 2005 Go Pro
    June 30, 2005 Go Pro
    March 31, 2005 Go Pro
    Dec. 31, 2004 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro

    About Free Cash Flow

    Free cash flow is the amount of cash generated by a business that is available for distribution among its security holders. Security holders include debt holders, equity holders, preferred stock holders, and convertible security holders. Specifically, free cash flow is used to pay dividends, make acquisitions, develop new products, invest in new property, plant and equipment, pay interest expenses, and reduce debt.

    According to many investors, free cash flow is the best indication of a company's ability to generate cash.
    Learn More

    Get data for

    GSK Free Cash Flow Benchmarks

    Companies
    AstraZeneca 1.784B
    Merck 1.99B
    Eli Lilly and Company 221.50M

    GSK Free Cash Flow Rankings

    Overall 99th percentile
    85 of 16782
    Sector 99th percentile
    6 of 1410 in Healthcare
    Industry 96th percentile
    5 of 135 in Drug Manufacturers - Major

    GSK Free Cash Flow Range, Past 5 Years

    Minimum -936.65M Sep 2012
    Maximum 2.707B Mar 2010
    Average 1.783B

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');